1998
DOI: 10.1073/pnas.95.13.7648
|View full text |Cite
|
Sign up to set email alerts
|

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

Abstract: To enhance the efficacy of DNA malaria vaccines, we evaluated the effect on protection of immunizing with various combinations of DNA, recombinant vaccinia virus, and a synthetic peptide.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
150
0
1

Year Published

1999
1999
2008
2008

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 207 publications
(154 citation statements)
references
References 24 publications
2
150
0
1
Order By: Relevance
“…Second, recent experiments have shown marked improvements in immunogenicity and efficacy when DNA vaccines are used as part of a heterologous prime-boost vaccination strategy. 19,20,15 It was possible that boosting with recombinant virus would overcome whatever suppressive effect of mixing was observed with DNA vaccines alone. However, in the current experiments, boosting with either of two recombinant vaccinia expressing PfCSP only partially overcame the suppressive effect of mixing on antibody responses to PfCSP (Figure 4a), and had no effect on the suppression of PfCSP-specific IFN-g responses in M9 (Figure 4b).…”
Section: Discussionmentioning
confidence: 99%
“…Second, recent experiments have shown marked improvements in immunogenicity and efficacy when DNA vaccines are used as part of a heterologous prime-boost vaccination strategy. 19,20,15 It was possible that boosting with recombinant virus would overcome whatever suppressive effect of mixing was observed with DNA vaccines alone. However, in the current experiments, boosting with either of two recombinant vaccinia expressing PfCSP only partially overcame the suppressive effect of mixing on antibody responses to PfCSP (Figure 4a), and had no effect on the suppression of PfCSP-specific IFN-g responses in M9 (Figure 4b).…”
Section: Discussionmentioning
confidence: 99%
“…31,32 Spleen cells from mice that 14 days earlier had received their second or third immunization were used in these determinations. These measurements were made 36 h after being incubated at 371C and 5% CO 2 with target cells infected with recombinant poxvirus expressing P. falciparum proteins or incubated with peptides.…”
Section: Ifnc Elispotmentioning
confidence: 99%
“…Many vaccine delivery systems [59,61,62] and vaccination protocols [19,63,64] are currently being investigated, and our demonstration that PfTRAP represents a target for IFN-+ T cell responses in naturally exposed West African adults provides us with a potentially protective response, which may be susceptible to boosting by vaccination. The PfTRAP epitopes identified in this study, in particular the conserved epitopes, may be useful components of a future malaria vaccine.…”
Section: Discussionmentioning
confidence: 99%